Skip to content

Adam M Veness, SVP, General Counsel and Sec. at Dianthus Therapeutics, sold DNTH on Aug 7, 2026

Data as of Oct 16

▼ SELL$356K3,217 shares at $110.61Adam M Veness SVP, General Counsel and Sec.DNTH Dianthus Therapeutics, Inc.
Watch DNTH
Traded
Aug 7, 2026
Disclosed
Aug 11, 2026
Filed
4 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Adam M Veness, SVP, General Counsel and Sec. at Dianthus Therapeutics, sold DNTH on Aug 7, 2026TRADEDDISCLOSED
DNTHSimilar stocks (XLV — its sector index fund), rebased to DNTH's price on the disclosure day
DNTH since disclosure
−33.6%
after the sale
Similar stocks (XLV) since disclosure
+5.2%
XLV — its sector index fund

Change in closing price from Aug 11, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLAdam M Veness SVP, General Counsel and Sec.DNTH Dianthus Therapeutics, Inc.$1.8Mdisclosed Aug 11 · filed 1 day after the trade
  2. ▼ SELLAdam M Veness SVP, General Counsel and Sec.DNTH Dianthus Therapeutics, Inc.$68.5Kdisclosed Aug 11 · filed 4 days after the trade

See every trade on DNTH →